ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 403 out of 1677

$662K Total Retail Price of All Prescriptions

Rank: 201 out of 1677

474 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,615 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 488 468 1 1
LEVOTHYROXINE SODIUM 358 335 2 5
OMEPRAZOLE 322 300 3 6
LISINOPRIL 286 277 4 3
METFORMIN HCL 236 222 5 7
NAMENDA 207 207 6 39
SYNTHROID 203 189 7 55
ZOLPIDEM TARTRATE 192 185 8 15
FUROSEMIDE 191 181 9 8
AMLODIPINE BESYLATE 167 158 10 2
CRESTOR 151 150 11 28
CELEBREX 143 137 12 102
EXELON 139 136 13 119
HYDROCODONE-ACETAMINOPHEN 134 116 S3 14 4
ATORVASTATIN CALCIUM 120 120 15 13
SERTRALINE HCL 117 110 16 26
HYDROCHLOROTHIAZIDE 107 104 17 9
PRAVASTATIN SODIUM 106 105 18 10
JANUVIA 102 101 19 70
CARBIDOPA-LEVODOPA 100 96 20 131
ESCITALOPRAM OXALATE 98 98 21 80
ALLOPURINOL 98 95 21 31
TAMSULOSIN HCL 96 88 23 34
FLUOXETINE HCL 95 84 24 49
METOPROLOL TARTRATE 88 69 25 12
DICLOFENAC SODIUM 84 74 26 95
TRAMADOL HCL 79 76 27 16
CARVEDILOL 78 74 28 20
GABAPENTIN 77 77 29 11
LOSARTAN POTASSIUM 75 72 30 25
METOPROLOL SUCCINATE 73 72 31 23
ATENOLOL 70 69 32 21
SPIRIVA 68 68 33 74
ACTOS 68 68 33 104
FENOFIBRATE 66 59 35 48
CITALOPRAM HBR 64 64 36 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 60 37 17
QUINAPRIL HCL 58 58 38 163
TRILIPIX 57 55 39 175
ALENDRONATE SODIUM 57 57 39 43
VESICARE 57 48 39 220
OLANZAPINE 57 56 39 189
PANTOPRAZOLE SODIUM 56 45 43 46
ESTRADIOL 56 53 R 43 129
NEXIUM 55 55 45 19
LANTUS SOLOSTAR 55 55 45 132
ACTONEL 54 54 47 335
MIRTAZAPINE 53 53 48 62
ADVAIR DISKUS 52 52 49 54
DIOVAN 51 51 50 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.